arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Shattuck Labs, Inc.

STTK
$7.26 ▲ +0.11 (+1.54%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
8 Visible periods
26 Metrics
Peer-ranked Benchmarks
Price Chart
26
Health
Poor
Bearish
auto_awesome

Analytical Summary

Shattuck Labs, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $505.2M
Dividend Yield
Revenue Growth -82.5%
Op. Margin None
ROIC -49.4%
FCF / Share $-0.57
Trailing P/E
Price / Book 5.6x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

8-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.00M
↓ -82.5%
Net Income Profit after all expenses
$-48.81M
↑ +35.3%
Operating Margin Operating profit as % of sales
-150.8%
↑ +59.4%
FCF / Share Free cash flow per share
$-0.57
↑ +51.9%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
14
Cash Quality
55

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 8 years · 30 quarters